What is a concise, step‑by‑step ACLS algorithm that addresses all cardiac rhythms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Streamlined ACLS Approach for All Cardiac Rhythms

The American Heart Association's ACLS algorithm divides all cardiac arrest rhythms into two pathways: shockable rhythms (VF/pulseless VT) requiring immediate defibrillation, and non-shockable rhythms (PEA/asystole) requiring immediate epinephrine—both built on the foundation of high-quality CPR with minimal interruptions. 1, 2

Universal Foundation: High-Quality CPR

All cardiac arrest management begins with immediate recognition and high-quality CPR, regardless of rhythm 1:

  • Push hard and fast: Compress at least 2 inches (5 cm) depth at 100-120 compressions per minute 1
  • Allow complete chest recoil after each compression 1
  • Minimize interruptions: Keep pauses under 10 seconds for rhythm checks, defibrillation, or pulse checks 1, 2
  • Avoid excessive ventilation: Use 30:2 compression-ventilation ratio without advanced airway, then 1 breath every 6 seconds (10 breaths/min) with continuous compressions once advanced airway placed 1
  • Rotate compressors every 2 minutes or sooner if fatigued 1

The Two-Pathway Algorithm

Pathway 1: Shockable Rhythms (VF/Pulseless VT)

  1. Immediate defibrillation with minimal interruption in compressions 1, 2:

    • Biphasic: 120-200 Joules (manufacturer recommendation)
    • Monophasic: 360 Joules 1
  2. Resume CPR immediately for 2 minutes after shock delivery before rhythm check 1, 2

  3. Establish IV/IO access and administer epinephrine 1 mg every 3-5 minutes 1

  4. For refractory VF/pVT (after 2-3 shocks), consider antiarrhythmics 1:

    • Amiodarone: 300 mg IV/IO bolus, then 150 mg second dose, OR
    • Lidocaine: 1-1.5 mg/kg IV/IO, then 0.5-0.75 mg/kg second dose
    • Note: The 2018 update changed from favoring amiodarone to considering either drug equally, as neither improves long-term survival 1
  5. Continue 2-minute CPR cycles with rhythm checks until ROSC or termination 1, 2

Pathway 2: Non-Shockable Rhythms (PEA/Asystole)

  1. Immediate high-quality CPR without delay for rhythm analysis 1, 2

  2. Administer epinephrine 1 mg IV/IO as soon as possible, then every 3-5 minutes 1, 2

  3. Search for reversible causes (H's and T's) while continuing CPR 1:

    • H's: Hypovolemia, Hypoxia, Hydrogen ion (acidosis), Hypo-/hyperkalemia, Hypothermia
    • T's: Tension pneumothorax, Tamponade (cardiac), Toxins, Thrombosis (pulmonary), Thrombosis (coronary)
  4. Rhythm check every 2 minutes during CPR cycles 1, 2

  5. If rhythm changes to VF/pVT, switch to shockable pathway 1

Critical Airway Management Points

  • Start with bag-mask ventilation using 30:2 ratio 1, 2
  • Consider advanced airway (endotracheal tube or supraglottic device) when appropriate, but never interrupt compressions for prolonged periods 1, 2
  • Confirm placement with waveform capnography immediately 1
  • Monitor PETCO2: If <10 mmHg, improve CPR quality 1
  • Once advanced airway placed, switch to continuous compressions with 1 breath every 6 seconds 1

Monitoring CPR Quality

Use physiologic parameters to optimize resuscitation 1:

  • Quantitative waveform capnography: Target PETCO2 >10 mmHg (ideally 10-20 mmHg during CPR) 1
  • Intra-arterial pressure monitoring if available: Target relaxation phase (diastolic) pressure >20 mmHg 1
  • Abrupt sustained increase in PETCO2 (typically ≥40 mmHg) indicates ROSC 1

Recognizing Return of Spontaneous Circulation (ROSC)

Stop CPR and confirm ROSC when 1, 3:

  • Pulse and blood pressure return
  • Abrupt sustained increase in PETCO2 (typically >40 mmHg)
  • Spontaneous arterial pressure waves with intra-arterial monitoring

Post-ROSC Management

Once ROSC achieved 2, 3:

  • Maintain mean arterial pressure ≥65 mmHg with vasopressors if needed
  • Target SpO2 92-98% to avoid both hypoxia and hyperoxemia
  • Initiate targeted temperature management for all patients not following commands
  • Do NOT routinely administer prophylactic antiarrhythmics after ROSC—no evidence supports improved survival 1, 3
  • Exception: Consider prophylactic lidocaine during EMS transport when recurrent VF/pVT would be logistically challenging to treat 1, 3

Common Pitfalls to Avoid

  • Never delay defibrillation to establish IV access or administer medications in shockable rhythms 2, 4
  • Avoid prolonged pulse checks: If no definite pulse within 10 seconds, resume CPR 2, 4
  • Don't interrupt compressions for advanced airway placement—use brief pauses only 1, 4
  • Avoid excessive ventilation, especially with advanced airway (causes increased intrathoracic pressure and decreased venous return) 1, 4
  • Don't treat compensatory sinus tachycardia post-ROSC with rate-control agents 3
  • Never base treatment solely on rhythm without clinical context—assess the whole patient 1

Tachycardia With Pulse Algorithm (Periarrest)

For patients with tachycardia and pulse 1:

  1. Assess stability: Is the patient unstable (altered mental status, chest pain, acute heart failure, hypotension, shock)? 1

  2. If unstable: Proceed immediately to synchronized cardioversion 1

  3. If stable, determine rhythm type 1:

    • Narrow-complex regular: Consider adenosine 6 mg rapid IV push, then 12 mg if needed 1
    • Wide-complex: Treat as VT until proven otherwise; consider antiarrhythmics (amiodarone, procainamide, or lidocaine) 1
  4. Critical point: Heart rates <150 bpm are unlikely to cause instability unless ventricular dysfunction present—look for underlying causes 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Adult Cardiac Arrest Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Ventricular Tachycardia with Pulse After ACLS

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

ACLS Ventricular Fibrillation Preparation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the latest guidelines for Advanced Cardiovascular Life Support (ACLS)?
What is the recommended management for cardiac arrest following a robotic Mitral Valve Repair (MVR), should Advanced Cardiovascular Life Support (ACLS) or Cardiopulmonary Arrest Life Support (CALS) be initiated?
What are the initial steps in Advanced Cardiovascular Life Support (ACLS) for a patient in cardiac arrest?
What are the Advanced Cardiovascular Life Support (ACLS) guidelines?
What is the immediate management for a patient who choked while eating and is in cardiac arrest, requiring the use of a transport monitor, crash cart, and AED?
How should a patient presenting to the emergency department with a suspected benzodiazepine overdose be evaluated and treated, including airway‑breathing‑circulation assessment, activated charcoal administration, indications and dosing of flumazenil, supportive care, monitoring, and disposition?
What is the recommended acute blood pressure management and subsequent therapy for a patient with primary hyperaldosteronism presenting with a hypertensive emergency?
Can aceclofenac be administered to a 13‑year‑old child as an alternative to ibuprofen when ibuprofen is unavailable?
How should tachycardia be managed in a patient with systemic sclerosis‑associated interstitial lung disease and pulmonary fibrosis, possibly with pulmonary arterial hypertension?
What is the minimum age for diclofenac use in children, and what are the recommended pediatric dosing and contraindications?
What is the recommended acamprosate dosing for an adult with alcohol dependence after detoxification, including dose adjustments for renal impairment, contraindications, side effects, monitoring, and use in pregnancy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.